Indeed, reduced endothelial NOS enzyme activity and eNOS uncoupling result in decreased NO bioavailability, and may be considered as the main factor underlying endothelial dysfunction that occurs in the MetS reloaded (Figure 15) [14,136,141,142,143]. Here, NOS3 is linked to metabolic syndrome.